Sentence examples for trials for assessing from inspiring English sources
If valid such a model would facilitate the design of simpler, cheaper, and better-focused trials for assessing new agents.
Reproducibility assessments and standardisation of the acquisition and data analysis methods are crucial when imaging biomarkers are used in multicentre trials for assessing response to treatment.
Second, In order to use a larger subset of trials for assessing the effect of experimental parameters, we repeated the application of two-factor ANOVA but here we used trial types (WR trials vs. PR trials) and number of test objects as independent parameters.
Consequently, randomized trials for assessing the relative benefits of operative vs. radiologic intervention are difficult.
The 4 S was one of the earliest randomized trials for assessing the effect of simvastatin in the secondary prevention of myocardial infarction [ 18].
Two-stage phase II trials for assessing survival probabilities can be designed that do not require prolonged suspension of patient accrual.
The aim of the health economics component of the study will be to inform the design of a full economic evaluation alongside the larger trial for assessing the intervention in terms of value for money.
Second, radiographic outcomes such as erosions, joint space narrowing and Sharp van der Heijde should be reported at least at baseline, during and at the end of the trial for assessing the efficacy [ 10] but they were not reported in the included trials.
We recently suggested a simple guidance for addressing dichotomous data for participants excluded from analyses of randomised trials and for assessing the associated risk of bias.
These measurements are suggested as outcome measures in clinical trials and for assessing the burden of clinical conditions by comparing clinical patients with the general population [ 16].
The potential to make longitudinal assessments of both clinical and biomarker responses has encouraged the development of novel clinical trial designs for assessing the impact of agents that aim to enhance response beyond that of endocrine agents alone.
